← Leaderboards
Jonghan Kim
Massachusetts General Hospital
$7,685,146
Attributed
$12,113,920
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,113,920 · 10
By mechanism
R01$9,502,239 · 4
R21$1,706,706 · 4
R00$727,599 · 1
K99$177,376 · 1
Top collaborators
- Hak Soo Choi9 shared
- Martin D Burke4 shared
- Mansoor M. Amiji3 shared
- Swati Betharia2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Kenneth D Bloch$14,282,889
- Randall T Peterson$17,953,472
- Hak Soo Choi$7,452,919
- Raymond T Chung$38,306,004
- Robert H Brown$15,031,077
Others in their field
Top investigators on “Iron”
- Russell E Ware · Duke University$35,947,157
- Christina Trahan Cain · Center For Construction Res And Training$33,579,614
- Edward I Solomon · Stanford University$22,331,425
- Mark Thomas Gladwin · Clinical Center$18,705,542
- Betsy Lozoff · University Of Michigan At Ann Arbor$18,414,412
- Edward A Neuwelt · Oregon Health And Science University$18,309,869
Research focus
IronTissuesToxic EffectIron OverloadAffectDoseMetalsAbsorptionSafetyNovel Therapeutic InterventionSiteChelating AgentsOxidative StressDrug KineticsLiverMediatingBaseResponseRattusReportingChronicDrug Or Chemical Tissue DistributionPhysiologyImpairment
Grant awards (28)
Long-Acting, Short-Residing Nanochelators for Iron Overload Therapy$717,218
R01 · FY2025 · HL
Mitochondrial iron export therapy for doxorubicin-induced cardiotoxicity$632,159
R01 · FY2025 · HL · contact PI
Long-Acting, Short-Residing Nanochelators for Iron Overload Therapy$702,873
R01 · FY2024 · HL
Mitochondrial iron export therapy for doxorubicin-induced cardiotoxicity$622,565
R01 · FY2024 · HL · contact PI
Long-Acting, Short-Residing Nanochelators for Iron Overload Therapy$734,218
R01 · FY2023 · HL
Mitochondrial iron export therapy for doxorubicin-induced cardiotoxicity$666,297
R01 · FY2023 · HL · contact PI
Restoration of Mitochondrial Function by Small-Molecule Iron Transporter in Friedreichâs Ataxia$234,750
R21 · FY2023 · NS · contact PI
Reversal of copper accumulation for the early prevention of Wilsonâs disease$218,373
R21 · FY2023 · HD · contact PI
Restoration of mitochondrial function by small-molecule iron transporter in Friedreichâs ataxia$195,625
R21 · FY2022 · NS · contact PI
Reversal of copper accumulation for the early prevention of Wilsonâs disease$193,409
R21 · FY2022 · HD · contact PI
Using a small molecule iron transporter to understand and treat FPN1 deficiencies in mice$675,650
R01 · FY2021 · HL
Nanochelation Therapies for Iron Overload Disorders$543,043
R01 · FY2021 · HL · contact PI
Intranasal gene delivery for Alzheimerâs disease$445,124
R21 · FY2021 · AG · contact PI
Using a small molecule iron transporter to understand and treat FPN1 deficiencies in mice$690,022
R01 · FY2020 · HL
Nanochelation Therapies for Iron Overload Disorders$643,608
R01 · FY2020 · HL · contact PI
Nanochelation Therapies for Iron Overload Disorders$181,302
R01 · FY2020 · HL · contact PI
Nanochelation-Based Theranostics for Alzheimer Disease$140,507
R01 · FY2020 · HL · contact PI
Using a small molecule iron transporter to understand and treat FPN1 deficiencies in mice$703,951
R01 · FY2019 · HL
Nanochelation Therapies for Iron Overload Disorders$543,904
R01 · FY2019 · HL · contact PI
Using a small molecule iron transporter to understand and treat FPN1 deficiencies in mice$747,056
R01 · FY2018 · HL
Nanochelation Therapies for Iron Overload Disorders$557,866
R01 · FY2018 · HL · contact PI
Oral Gene Delivery to Improve Iron Overload Disorders$229,025
R21 · FY2017 · EB · contact PI
Oral Gene Delivery to Improve Iron Overload Disorders$190,400
R21 · FY2016 · EB · contact PI
Influence of HFE on metal pharmacokinetics and neurotoxicity$236,002
R00 · FY2014 · ES · contact PI
Influence of HFE on metal pharmacokinetics and neurotoxicity$242,597
R00 · FY2013 · ES · contact PI
Influence of HFE on metal pharmacokinetics and neurotoxicity$249,000
R00 · FY2012 · ES · contact PI
Influence of HFE on metal pharmacokinetics and neurotoxicity$89,711
K99 · FY2011 · ES · contact PI
Influence of HFE on metal pharmacokinetics and neurotoxicity$87,665
K99 · FY2010 · ES · contact PI